Can AI Predict the Next Big IPO? Crunchbase Thinks So.
The data startup is using AI to forecast startup funding, acquisitions and public offerings—but its biggest challenge may be ...
Anbio Biotechnology prices $8M IPO at $5 per share
Global diagnostic company, Anbio Biotechnology (NNNN) priced its initial public offering of 1.6M shares at $5.00 per share.
Revolut's Road to IPO Will Test Fintech’s Hype
That’s worse than many supposedly lumbering incumbents, and miles behind the most efficient including names such as Italy’s ...
Anbio Biotechnology Announces Pricing of Initial Public Offering
The Company expects to receive aggregate gross proceeds of US$8 million from the Offering, before deducting underwriting discounts and other related expenses. The Offering is expected to close on or ...
First-Day IPO Trading Flops Threaten Next Wave of US Debuts
Wall Street loves a perfectly choreographed IPO, with more shares offered and prices increased in the lead-up to the deal, to ...